NCT07335341

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 50 (estimated)
• Sponsor: Medtronic Endovascular · Industry
• Sex: All
• Age: 22 Years
• Healthy volunteers: Not accepted

Summary

The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems

Detailed description

The Liberant Clinical Assessment is a multicenter, prospective per patient HCP recollection survey. Participating HCPs will document their individual case experience following routine utilization of Liberant in accordance with the approved device labeling. Individual use cases will be entered within 72 hours of device usage to identify periprocedural incidents of risk and evaluate device performance. At least 50 use cases will be collected and aggregated from at least 10 participating HCPs. This data collection is for a single point in time, with no patient follow-up. Individual HCP responses for each case will be aggregated by a third party vendor.

Conditions

• Venous Embolism of Lower Extremities (Diagnosis)
• Arterial Embolism and Thrombosis
• Acute DVT of Lower Extremity
• Chronic DVT of Lower Extremity
• DVT
• Deep Vein Thrombosis Leg
• Thrombus in the Peripheral Venous Vasculature
• Peripheral Arterial Disease
• Acute Limb Ischemia
• Lower Extremity Acute Limb Ischemia
• LE ALI

Interventions

Type	Name	Description
DEVICE	Liberant Thrombectomy System	The Liberant thrombectomy system is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems

Timeline

• Start date: 2026-03-01
• Primary completion: 2026-08-01
• Completion: 2026-08-01
• First posted: 2026-01-13
• Last updated: 2026-03-04

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study